Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine

Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine Publisher Pubmed

Jafarpour Azami S^{1, 2} ; Mohammad Rahimi H¹ ; Mirjalali H¹ ; Zali MR³

Source: World Journal of Microbiology and Biotechnology Published:2021

Abstract

Abstract: Toxoplasma gondii is a worldwide protozoan parasite that infects almost all warm-blooded animals. Although human toxoplasmosis is mostly latent, pregnant women and immunocompromised patients need effective treatment. There are drugs of choice for treatment of toxoplasmosis; however, due to their side effects and/or their disease stage-specificity, prescription of them is limited. During recent years, nanomedicine has been employed to overcome limitations of conventional drugs. Here, we provided a state-of-the-art review of experimental toxoplasmosis treatment using nanotechnology. Graphic abstract: [Figure not available: see fulltext.] © 2021, The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Related Docs

View other Related Docs

1. Nanoemulsion of Spiramycin Against Tachyzoites of Toxoplasma Gondii, Rh Strain: Preparation, Toxicology, and Efficacy Studies, Iranian Journal of Public Health (2023)

2. Nanoemulsion of Atovaquone As a Promising Approach for Treatment of Acute and Chronic Toxoplasmosis, European Journal of Pharmaceutical Sciences (2018)

3. Curcumin Nanoemulsion As a Novel Chemical for the Treatment of Acute and Chronic Toxoplasmosis in Mice, International Journal of Nanomedicine (2018)

Experts (# of related papers)

View all Related Experts

Saeedeh Shojaee (11)

Hossein Keshavarz Valian (10)

Style	Citing Format
MLA	Jafarpour Azami S, et al.. "Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine." World Journal of Microbiology and Biotechnology, vol. 37, no. 3, 2021, pp. -.
APA	Jafarpour Azami S, Mohammad Rahimi H, Mirjalali H, Zali MR (2021). Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine. World Journal of Microbiology and Biotechnology, 37(3), -.
Chicago	Jafarpour Azami S, Mohammad Rahimi H, Mirjalali H, Zali MR. "Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine." World Journal of Microbiology and Biotechnology 37, no. 3 (2021): -.
Harvard	Jafarpour Azami S et al. (2021) 'Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine', World Journal of Microbiology and Biotechnology, 37(3), pp. -.
Vancouver	Jafarpour Azami S, Mohammad Rahimi H, Mirjalali H, Zali MR. Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine. World Journal of Microbiology and Biotechnology. 2021;37(3):-.
BibTex	@article{ author = {Jafarpour Azami S and Mohammad Rahimi H and Mirjalali H and Zali MR}, title = {Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine}, journal = {World Journal of Microbiology and Biotechnology}, volume = {37}, number = {3}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Jafarpour Azami S AU - Mohammad Rahimi H AU - Mirjalali H AU - Zali MR TI - Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine JO - World Journal of Microbiology and Biotechnology VL - 37 IS - 3 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Abstract